Bayer AG (FRA:BAYN) received a €118.00 ($138.82) price objective from stock analysts at equinet AG in a report released on Friday. The brokerage currently has a “buy” rating on the healthcare company’s stock.
Several other equities research analysts have also recently weighed in on BAYN. Jefferies Group LLC set a €150.00 ($176.47) price target on Bayer AG and gave the company a “buy” rating in a research note on Friday, June 16th. Citigroup Inc. set a €130.00 ($152.94) target price on Bayer AG and gave the stock a “buy” rating in a research note on Thursday, June 22nd. Deutsche Bank AG set a €124.00 ($145.88) target price on Bayer AG and gave the stock a “buy” rating in a research note on Monday, June 26th. UBS AG set a €125.00 ($147.06) target price on Bayer AG and gave the stock a “buy” rating in a research note on Tuesday, June 27th. Finally, Nord/LB reaffirmed a “neutral” rating on shares of Bayer AG in a research note on Wednesday, June 28th. Eight analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of €121.55 ($142.99).
Bayer AG (FRA BAYN) opened at 118.125 on Friday. The firm’s 50-day moving average price is €111.39 and its 200-day moving average price is €112.22. Bayer AG has a one year low of €85.72 and a one year high of €123.83. The company has a market cap of €103.02 billion and a PE ratio of 20.433.
ILLEGAL ACTIVITY NOTICE: “equinet AG Analysts Give Bayer AG (BAYN) a €118.00 Price Target” was originally published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2017/10/13/equinet-ag-analysts-give-bayer-ag-bayn-a-118-00-price-target.html.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.